Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Father Flanagan'S Boys' Home Doing Business AS Boys Town National Research Hospital has 3 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 3 distinct examiners and 3 distinct art units. This level of distribution indicates that the portfolio's current prosecution is split across multiple technical and administrative fronts within the office.
The busiest examiner, DENT, ALANA HARRIS, is handling 1 pending office action. Since there are 3 pending office actions in total, each action is assigned to a different examiner. This distribution across 3 distinct examiners requires the practitioner to manage three separate sets of examiner preferences and deadlines simultaneously. Each of the 3 pending office actions must be handled with a unique strategy that addresses the specific concerns of the assigned examiner.
The involvement of 3 distinct art units suggests that the 3 pending office actions may be subject to different internal policies or examination speeds. Practitioners must carefully coordinate their responses to ensure a consistent strategy across all 3 distinct examiners. Successfully resolving the 1 action with DENT, ALANA HARRIS is one of three parallel goals for the portfolio. This structure requires the legal team to be familiar with the specific policies of all 3 distinct art units.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (33%) |
| §112 only | 1 (33%) |
| Double-patenting + other | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DENT, ALANA HARRIS | 1 | 44.2% | +32.0% |
| DRISCOLL, LORA E BARNHART | 1 | 32.0% | +20.0% |
| HANEY, AMANDA MARIE | 1 | 36.4% | +44.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18176152 | TESTING ASSAY FOR SCREENING AND DIAGNOSIS OF USHER, PENDRED, JERVELL, AND LANGE-NIELSEN SYNDROMES | HANEY, AMANDA MARIE | 4d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18176152 | TESTING ASSAY FOR SCREENING AND DIAGNOSIS OF USHER, PENDRED, JERVELL, AND LANGE-NIELSEN SYNDROMES | HANEY, AMANDA MARIE | 4d overdue |
| 18356417 | GENETIC VARIATIONS ASSOCIATED WITH BENIGN PAROXYSMAL POSITIONAL VERTIGO | DENT, ALANA HARRIS | 26d |
| 18248003 | COMBINATION THERAPY FOR ALPORT RENAL DISEASE | DRISCOLL, LORA E BARNHART | — |
| Art Unit | Apps |
|---|---|
| 1643 | 1 |
| 3991 | 1 |
| 1682 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18356417 | GENETIC VARIATIONS ASSOCIATED WITH BENIGN PAROXYSMAL POSITIONAL VERTIGO | DENT, ALANA HARRIS | 1643 | §112 | Non-Final OA | 26d | Pending | Jul 21, 2023 |
| 18248003 | COMBINATION THERAPY FOR ALPORT RENAL DISEASE | DRISCOLL, LORA E BARNHART | 3991 | §103DP | Non-Final OA | — | Pending | Apr 05, 2023 |
| 18176152 | TESTING ASSAY FOR SCREENING AND DIAGNOSIS OF USHER, PENDRED, JERVELL, AND LANGE-NIELSEN SYNDROMES | HANEY, AMANDA MARIE | 1682 | §101§102§103 | Non-Final OA | 4d overdue | Pending | Feb 28, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial